Hype or Hope for Cancer

DR. WILLIAMMAKIS‘ UPDATED IVERMECTIN & FENBENDAZOLE CANCER PROTOCOL IS GETTING PEOPLE TALKING Cancer patients aren’t saving this chart because it’s controversial. They’re saving it because they’re looking for answers. And according to the protocol attributed to Dr. William Makis, one of the biggest mistakes people make is assuming every cancer case should follow the same approach.
That’s why this chart doesn’t show one dose. It shows FOUR.

LOW. MEDIUM. HIGH. VERY HIGH. The goal? To adjust the approach based on: Cancer aggressiveness Tumor burden Metastatic spread Overall prognosis Individual response ━━━━━━━━━━━━━━

LOW DOSE IVERMECTIN ≤ 0.5 mg/kg 3x per week FENBENDAZOLE 222 mg/day 3 days on, 4 days off Often discussed for: • Remission support • Prevention • Strong family history • Higher risk individuals ━━━━━━━━━━━━━━

MEDIUM DOSE IVERMECTIN 1.0 mg/kg daily FENBENDAZOLE 222 mg/day 6 days per week Often discussed for: • Most active cancers • Common starting approach ━━━━━━━━━━━━━━

HIGH DOSE IVERMECTIN 2.0 mg/kg daily FENBENDAZOLE 444 mg/day 6 days per week Often discussed for: • Aggressive cancers • Brain cancers • Leukemia • Pancreatic cancer ━━━━━━━━━━━━━━

VERY HIGH DOSE IVERMECTIN ≥ 2.5 mg/kg daily FENBENDAZOLE 888 to 1000 mg/day 6 days per week Often discussed for: • Extensive metastatic disease • Poor prognosis cases ━━━━━━━━━━━━━━

ADDITIONAL PROTOCOL NOTES

Many patients combine Ivermectin and Fenbendazole

Some alternate Fenbendazole with Mebendazole

Fenbendazole is commonly taken with fatty meals

Liver support is frequently discussed

Long term use and monitoring are commonly emphasized ━━━━━━━━━━━━━━

WHAT MAKES THIS PROTOCOL DIFFERENT? It’s not simply the dosages. It’s the idea behind them. Dr. Makis argues that cancer isn’t one disease. A patient in remission is different from a patient with widespread metastatic disease. A slow growing cancer is different from an aggressive one. And because of that, many people believe a one size fits all approach may not always make sense. That’s one reason why interest in repurposed medicines continues to grow.

Researchers have spent years investigating how compounds like Ivermectin and Fenbendazole may interact with: • Cancer metabolism • Cancer stem cells • Mitochondrial function • Tumor signaling pathways • Treatment resistance mechanisms • Cellular energy production Whether these findings ultimately change clinical practice remains to be seen. But one thing is undeniable: More cancer patients, caregivers, and researchers are discussing repurposed medicines today than ever before. And that’s exactly why charts like this keep getting shared.

Save this chart now. Six months from now, you’ll wish you knew where to find it. Repost it so more people researching cancer protocols can see it. Have you been following Dr. William Makis’ work on Ivermectin and Fenbendazole? Many people researching Ivermectin and Fenbendazole have discovered @rxmeds_store.

(1) Andrew Panella on X: “Dr. William Makis MD. His anti-cancer protocols have potentially cured thousands of patients… But Big Pharma can’t profit from his methods so they suppress him. Here are his top 7 methods to fight cancer and protocols for each stage of it (bookmark this): https://t.co/PRtC6EgzoM” / X

DR. WILLIAMMAKIS HAS PUBLICLY SHARED THE ALTERNATIVE CANCER PROTOCOL HE SAYS HE’S USING, AND IT’S SPARKING DEBATE ACROSS THE WORLD. Rather than relying on a single treatment, Dr. Makis combines repurposed medicines, targeted bioactive compounds, and immune support into one comprehensive protocol. The protocol cites published studies alongside several recommendations and is designed, according to Dr. Makis, to target cancer through multiple biological pathways. Core Repurposed Medicines Ivermectin • 1.5 mg/kg/day • Once daily with food • Split into doses of 12 mg or less at a time • Reference: Zhou (2021) Fenbendazole • 1,500 mg/day • Split into two daily doses • Reference: Park (2021) Modified Citrus Pectin • 15 g/day • One-third scoop mixed with water or juice • Taken three times daily with food Optional Bioactive Compounds Black Seed Oil (Thymoquinone): 2,000 mg/day (split doses, empty stomach) Berberine: 1,000 mg/day (split into two doses with food) Olive Leaf Extract (Oleuropein): 1,000 mg/day (split into two doses with food) Immune Support Vitamin D3 – 20,000 IU daily Vitamin K2 – 100 mcg daily Turkey Tail Mushroom – 1,000 mg/day with food

According to Dr. Makis, the goal isn’t to rely on a single medicine.

It’s to combine therapies that may work through different biological mechanisms as part of an integrated strategy. Whether you agree with this approach or not, protocols centered on Ivermectin and Fenbendazole have become some of the most discussed topics in repurposed medicine, with growing interest from patients, physicians, and researchers alike. One question remains… If low cost generic medicines show enough promise for physicians to build protocols around them, should they receive the same level of scientific investigation as expensive patented drugs? What’s your opinion?

Knowledge only has value when it’s shared. Save this protocol and send it to someone researching Ivermectin, Fenbendazole, or alternative cancer protocols.